NASDAQ: WHWK
Whitehawk Therapeutics Inc Stock Ownership - Who owns Whitehawk Therapeutics?

Insider buying vs selling

Have Whitehawk Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Baiteng ZhaoDirector2025-03-041,250,000$2.40
$3.00MBuy
Bryan BallChief Technical Operations Officer and SVP Manufacturing Operations2025-03-04100,000$2.40
$240.00kBuy
Caley CasteleinDirector2025-03-041,666,000$2.40
$4.00MBuy
Anupam DalalDirector2025-03-041,561,000$2.40
$3.75MBuy
Bryan BallChief Technical Operations Officer and SVP Manufacturing Operations2025-03-032,147$2.35
$5.05kSell
Scott M. GiacobelloCHIEF FINANCIAL OFFICER2025-03-032,806$2.35
$6.59kSell
David James LennonCHIEF EXECUTIVE OFFICER2025-03-035,690$2.35
$13.37kSell
David James LennonCHIEF EXECUTIVE OFFICER2024-10-039,689$1.94
$18.80kSell
Neil DesaiEXECUTIVE CHAIRMAN2024-09-0340,000$1.71
$68.32kSell
Neil DesaiEXECUTIVE CHAIRMAN2024-08-055,652$1.34
$7.60kSell

1 of 2

WHWK insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when WHWK insiders and whales buy or sell their stock.

WHWK Shareholders

What type of owners hold Whitehawk Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Muneer A. Satter11.93%5,621,835$11.75MInsider
Orbimed Advisors LLC11.03%5,193,946$10.86MInsider
Chau Quang Khuong11.03%5,193,946$10.86MInsider
Qvt Financial LP9.59%4,515,709$9.44MInstitution
Orbimed Advisors LLC8.84%4,166,000$8.71MInstitution
Novartis Bioventures Ltd8.60%4,049,804$8.46MInsider
Suvretta Capital Management LLC7.85%3,700,000$7.73MInstitution
Behzad Aghazadeh7.37%3,471,752$7.26MInsider
Anupam Dalal7.24%3,411,532$7.13MInsider
Acuta Capital Partners LLC7.24%3,410,402$7.13MInstitution

1 of 3

WHWK vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
WHWK44.74%55.26%Net Buying
FBRX45.00%55.00%Net BuyingNet Selling
SAVA31.06%68.94%Net Selling
CCCC78.03%21.97%Net SellingNet Buying
CRBP45.00%55.00%Net BuyingNet Selling

Whitehawk Therapeutics Stock Ownership FAQ

Who owns Whitehawk Therapeutics?

Whitehawk Therapeutics (NASDAQ: WHWK) is owned by 67.52% institutional shareholders, 83.39% Whitehawk Therapeutics insiders, and 0.00% retail investors. Muneer A. Satter is the largest individual Whitehawk Therapeutics shareholder, owning 5.62M shares representing 11.93% of the company. Muneer A. Satter's Whitehawk Therapeutics shares are currently valued at $11.75M.

If you're new to stock investing, here's how to buy Whitehawk Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.